USX:HRMY - Harmony Biosciences Holdings Inc Harmony Biosciences Holdings
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance
Balance Sheet Cash Flow Income Statement Key Ratios
Adjust Display Metrics

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 Graph
Insider Holdings (%) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] - - - - - - - - - - - -
Net Margin [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 7.3%
-
4.32%
-40.9%
11.33%
162.5%
14.71%
29.9%
15.95%
8.5%
38.84%
143.5%
41.44%
6.7%
40.17%
-3.1%
40.14%
-0.1%
27.82%
-30.7%
22.14%
-20.4%
22.3%
0.7%
Gross Margin [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 82.62%
0.0%
82.4%
-0.3%
81.82%
-0.7%
81.93%
0.1%
81.87%
-0.1%
81.43%
-0.5%
80.93%
-0.6%
81.02%
0.1%
80.83%
-0.2%
80.63%
-0.2%
79.17%
-1.8%
79.28%
0.1%
Operating Margin [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 23.78%
15.4%
24.64%
3.6%
28.66%
16.3%
30.37%
6.0%
30.29%
-0.3%
25.25%
-16.6%
27.45%
8.7%
28.21%
2.8%
29.44%
4.3%
36.8%
25.0%
32.99%
-10.4%
32.98%
0.0%
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 235.39M
17.9%
270.51M
14.9%
305.44M
12.9%
331.08M
8.4%
364.29M
10.0%
400.76M
10.0%
437.86M
9.3%
471.67M
7.7%
498.86M
5.8%
541.92M
8.6%
582.02M
7.4%
617.51M
6.1%
Total Assets [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 359.69M
6.7%
391.09M
8.7%
433.44M
10.8%
464M
7.1%
505.03M
8.8%
643.46M
27.4%
673.87M
4.7%
715.09M
6.1%
760.18M
6.3%
777.77M
2.3%
811.45M
4.3%
846.99M
4.4%
Total Liabilities [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 233.14M
1.6%
239.07M
2.5%
246.94M
3.3%
249.5M
1.0%
258.5M
3.6%
299.58M
15.9%
271.03M
-9.5%
272.05M
0.4%
275.01M
1.1%
296.43M
7.8%
344.46M
16.2%
331.59M
-3.7%
Total Equity [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 126.55M
17.3%
152.02M
20.1%
186.51M
22.7%
214.5M
15.0%
246.53M
14.9%
343.88M
39.5%
402.84M
17.1%
443.04M
10.0%
485.17M
9.5%
481.33M
-0.8%
466.99M
-3.0%
515.39M
10.4%
Operating CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 49.48M
36.5%
71.07M
43.6%
98.56M
38.7%
114.88M
16.6%
130.54M
13.6%
155.32M
19.0%
144.47M
-7.0%
158.17M
9.5%
161.5M
2.1%
169.4M
4.9%
219.39M
29.5%
207.97M
-5.2%
Beginning Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 77.03M
6.6%
222.49M
188.8%
229.38M
3.1%
141.92M
-38.1%
160.44M
13.0%
190.45M
18.7%
235.06M
23.4%
225.25M
-4.2%
237.28M
5.3%
262.09M
10.5%
244.53M
-6.7%
288.71M
18.1%
End Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 160.44M
13.0%
190.45M
18.7%
235.06M
23.4%
225.25M
-4.2%
237.28M
5.3%
262.09M
10.5%
244.53M
-6.7%
288.71M
18.1%
317.67M
10.0%
324.85M
2.3%
311.93M
-4.0%
333.25M
6.8%
Free Cash Flow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -52.72M
-
-31.23M
-
-1.74M
-
74.54M
-
90.36M
21.2%
115.15M
27.4%
104.29M
-9.4%
158.05M
51.5%
161.21M
2.0%
169.19M
5.0%
219.07M
29.5%
207.65M
-5.2%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 23.21M
156.1%
11.68M
-49.7%
34.6M
196.3%
48.7M
40.8%
58.11M
19.3%
155.67M
167.9%
181.47M
16.6%
189.47M
4.4%
200.24M
5.7%
150.75M
-24.7%
128.85M
-14.5%
137.7M
6.9%
Diluted Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 17.19M
-
11.68M
-32.1%
34.6M
196.3%
48.7M
40.8%
58.11M
19.3%
155.67M
167.9%
181.47M
16.6%
189.47M
4.4%
200.24M
5.7%
150.75M
-24.7%
128.85M
-14.5%
137.7M
6.9%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 0.302
-
1.87
520.0%
0.58
-69.0%
0.8
37.9%
0.95
18.7%
2.56
169.5%
2.97
16.0%
3.1
4.4%
3.28
5.8%
2.47
-24.7%
2.13
-13.8%
2.32
8.9%
Return On Equity (%) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 44.54%
518.3%
9.47%
-78.7%
24.39%
157.6%
30.21%
23.9%
31.15%
3.1%
62.78%
101.5%
61.58%
-1.9%
57.63%
-6.4%
54.73%
-5.0%
36.54%
-33.2%
29.63%
-18.9%
28.73%
-3.0%
Return On Assets (%) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 6.51%
-
3.28%
-49.5%
8.04%
144.9%
12.15%
51.2%
13.44%
10.6%
30.09%
123.9%
32.78%
8.9%
32.14%
-1.9%
31.65%
-1.5%
21.21%
-33.0%
17.35%
-18.2%
17.63%
1.6%
Values are in USD whenever applicable | Fiscal year ends on December 31
Powered by Morningstar

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms